QuickView for WHI-P97 (compound)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
3. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
4. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)

1. Novel Diagnostic and Therapeutic Options for KMT2A-Rearranged Acute Leukemias.
2. Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cel…
3. Tyrosine kinase inhibitors against EGF receptor-positive malignancies.
4. Thrombin induces expression of cytokine-induced SH2 protein (CIS) in rat brain astrocytes: involveme…
5. Tyrosine kinase inhibitors: a new approach for asthma.

There were no clinical trials for WHI-P97